Is Hormone Replacement Therapy Safe in Women With a BRCA Mutation?: A Systematic Review of the Contemporary Literature.

CONCLUSIONS: Decisions regarding the use of HT in women who undergo BSO after detection of a BRCA mutation must be individualized based on careful consideration of the risks and benefits. However, the risks of a subsequent cancer diagnosis appear small, particularly in regards to the benefits of treatment afforded by HT. PMID: 26840041 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26840041?dopt=Abstract

Source: Clinical Breast Cancer - February 2, 2016 Category: Cancer & Oncology Authors: Birrer N, Chinchilla C, Del Carmen M, Dizon DS Tags: Am J Clin Oncol Source Type: research